Reposted by Sina Azadnajafabad, MD, MPH
Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in #PancreaticCancer: A Systematic Review 🧪 onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in Pancreatic Cancer: A Systematic Review
Background Pancreatic cancer (PC) is a lethal malignancy with a 5-year survival rate of 13% as the 7th leading cause of cancer-related death worldwide. Most patients are ineligible for resection at ...
